Some researchers [18] explored the prognostic value of Ki- 67 in the whole cohort of breast cancer, but the number of cases in TNBC and Her2+ classes was quite small and this may limit the ability of Ki-67 to identify clinically distinct subclasses. Here, ERBB2 is linked to breast carcinoma.